Literature DB >> 24242295

Annexin A1 in malignant tumors: current opinions and controversies.

Rong Biaoxue1, Cai Xiguang, Yang Shuanying.   

Abstract

Annexin A1 is a 37 kDa calcium and phospholipid-binding protein that participates in several biological processes, such as inflammatory reactions, modulation of cell proliferation, regulation of cell death signaling, apoptosis, and, most importantly, tumor formation and development. Although annexin A1 has been implicated in the biology of various tumors, the findings are highly controversial and information regarding the underlying mechanism remains limited. Moreover, the mechanism by which annexin A1 participates in carcinogenesis and tumor progression is rather unclear. In the current study, we review the important biological functions of annexin A1 in different tumors. This work indicates that annexin A1 is a possible target for novel therapeutic intervention and that it is a potential biomarker for tumor diagnosis and screening.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24242295     DOI: 10.5301/jbm.5000046

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  13 in total

1.  Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.

Authors:  Y Niu; X Yang; Y Chen; X Jin; Y Xie; Y Tang; L Li; S Liu; Y Guo; X Li; L Duan; H Wang
Journal:  Clin Transl Oncol       Date:  2019-01-29       Impact factor: 3.405

2.  Upregulation of annexin A1 expression by butyrate in human melanoma cells induces invasion by inhibiting E-cadherin expression.

Authors:  Jimin Shin; In-Sung Song; Jhang Ho Pak; Sung-Wuk Jang
Journal:  Tumour Biol       Date:  2016-09-10

3.  HYOU1, Regulated by LPLUNC1, Is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis.

Authors:  Yujuan Zhou; Qianjin Liao; Xiayu Li; Hui Wang; Fang Wei; Jie Chen; Jing Yang; Zhaoyang Zeng; Xiaofang Guo; Pan Chen; Wenling Zhang; Ke Tang; Xiaoling Li; Wei Xiong; Guiyuan Li
Journal:  J Cancer       Date:  2016-01-12       Impact factor: 4.207

4.  Knockdown of Annexin A1 Enhances Radioresistance and Inhibits Apoptosis in Nasopharyngeal Carcinoma.

Authors:  Li Liao; Wen-Jing Yan; Chun-Mei Tian; Mao-Yu Li; Yong-Quan Tian; Gu-Qing Zeng
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

5.  Identification and dynamic changes of RNAs isolated from RALY-containing ribonucleoprotein complexes.

Authors:  Annalisa Rossi; Albertomaria Moro; Toma Tebaldi; Nicola Cornella; Lisa Gasperini; Lorenzo Lunelli; Alessandro Quattrone; Gabriella Viero; Paolo Macchi
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

6.  Annexin A1 is elevated in patients with COPD and affects lung fibroblast function.

Authors:  Tianwen Lai; Yanyu Li; Zongjiong Mai; Xiaoxia Wen; Yingying Lv; Zhanqing Xie; Quanchao Lv; Min Chen; Dong Wu; Bin Wu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-02-05

7.  miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing.

Authors:  Raffaella Belvedere; Pasquale Saggese; Emanuela Pessolano; Domenico Memoli; Valentina Bizzarro; Francesca Rizzo; Luca Parente; Alessandro Weisz; Antonello Petrella
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

8.  In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer.

Authors:  Soulaimane Aboulouard; Maxence Wisztorski; Marie Duhamel; Philippe Saudemont; Tristan Cardon; Fabrice Narducci; Anne-Sophie Lemaire; Firas Kobeissy; Eric Leblanc; Isabelle Fournier; Michel Salzet
Journal:  Cell Rep Med       Date:  2021-06-15

9.  Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation.

Authors:  Jin-Feng Zhu; Wei Huang; Hong-Mei Yi; Ta Xiao; Jiao-Yang Li; Juan Feng; Hong Yi; Shan-Shan Lu; Xin-Hui Li; Rou-Huang Lu; Qiu-Yan He; Zhi-Qiang Xiao
Journal:  Cell Death Dis       Date:  2018-11-20       Impact factor: 8.469

10.  Annexin A12-26 Treatment Improves Skin Heterologous Transplantation by Modulating Inflammation and Angiogenesis Processes.

Authors:  Jéssica Zani Lacerda; Carine Cristiane Drewes; Kallyne Kioko Oliveira Mimura; Caroline de Freitas Zanon; Tahera Ansari; Cristiane Damas Gil; Karin Vicente Greco; Sandra Helena Poliselli Farsky; Sonia Maria Oliani
Journal:  Front Pharmacol       Date:  2018-09-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.